Literature DB >> 22018796

[Therapeutic non-compliance with insulin in the treatment of diabetes mellitus 2].

Emilio Márquez Contreras1, Nieves Martell Claros, Vicente Gil Guillén, José Joaquín Casado Martínez, José Luis Martín de Pablos, Javier Ferraro García, Rosa Chaves González, Amalia Fernández Ortega.   

Abstract

OBJECTIVE: To determine the percentage of therapeutic noncompliance among type 2 diabetes patients on treatment with insulin.
DESIGN: Prospective multicentre study.
SETTING: Nine Primary Care Health Centre in Huelva (Spain). PARTICIPANTS: A total of 121 type 2 diabetics, who, in the opinion of their doctor, need to start treatment with insulin or have their insulin treatment modified. MAIN MEASUREMENTS: Five visits were made (enrolment, 6, 12, 18 and 24 months). The variables analysed were, fasting blood glucose, glycosylated haemoglobin, compliance with insulin treatment, measured by counting insulin units. The percentage compliance (PC) was calculated by (PC = Total No. of insulin units expected to be consumed / Total No. of insulin units that should have been taken x 100). A complier was considered as one who achieved a PC between 80 and 100%.
RESULTS: There were 103 evaluable subjects (85.8%) with a mean age of 66.4 (SD 11.6) years, and 45 were male (42.8%). The mean percentage compliance with insulin was 90.9% (95% CI, 84.2-97.6%). At the 6, 12, 18 and 24 months visits it was 92.1% (95% CI, 85.6-98.6%), 92.3, 90.1 and 89.2% (95% CI, 81.7-96.7%), respectively. Overall patient compliance was 74.75% (95% CI, 64.3-85.2%). For the visits, compliance was 82.5% (95% CI, 73.3-91.7%), 77.7%, 73.8% and 71.8% (95% CI, 60.9-82.7%), respectively (P<.05 initial-final).
CONCLUSIONS: A quarter of the diabetic patients did not comply with their insulin treatment. Copyright Â
© 2010 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018796      PMCID: PMC7025128          DOI: 10.1016/j.aprim.2010.11.013

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  20 in total

1.  Impact of dosage frequency on patient compliance.

Authors:  A H Paes; A Bakker; C J Soe-Agnie
Journal:  Diabetes Care       Date:  1997-10       Impact factor: 19.112

2.  [Analysis of studies published on hypertension treatment non-compliance in Spain between 1984 and 2005].

Authors:  Emilio Márquez Contreras; Vicente Gil Guillén; José Joaquín Casado Martínez; Nieves Martel Claros; Mariano De la Figuera von Wichmann; José Luis Martín de Pablos; Francisco Atienza Martín; Teresa Gros García; Jacinto Espinosa García
Journal:  Aten Primaria       Date:  2006-10-15       Impact factor: 1.137

3.  A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy.

Authors:  Scott Devine; Anna Vlahiotis; Heather Sundar
Journal:  J Med Econ       Date:  2010       Impact factor: 2.448

4.  Utilization of oral hypoglycemic agents in a drug-insured U.S. population.

Authors:  S J Boccuzzi; J Wogen; J Fox; J C Sung; A B Shah; J Kim
Journal:  Diabetes Care       Date:  2001-08       Impact factor: 19.112

5.  Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit.

Authors:  A D Morris; D I Boyle; A D McMahon; S A Greene; T M MacDonald; R W Newton
Journal:  Lancet       Date:  1997-11-22       Impact factor: 79.321

6.  [Therapy compliance in cases of hyperlipaemia, as measured through electronic monitors. Is a reminder calendar to avoid forgetfulness effective?].

Authors:  Emilio Márquez Contreras; José Joaquín Casado Martínez; Juan Motero Carrasco; José Luis Martín de Pablos; Rosa Chaves González; Carmen Losada Ruiz; José Carlos Pastoriza Vilas
Journal:  Aten Primaria       Date:  2007-12       Impact factor: 1.137

7.  Assessment of sulfonylurea adherence and metabolic control.

Authors:  B J Mason; J R Matsuyama; S G Jue
Journal:  Diabetes Educ       Date:  1995 Jan-Feb       Impact factor: 2.140

8.  A novel method for measuring patients' adherence to insulin dosing guidelines: introducing indicators of adherence.

Authors:  Massoud Toussi; Carine Choleau; Gérard Reach; Michel Cahané; Avner Bar-Hen; Alain Venot
Journal:  BMC Med Inform Decis Mak       Date:  2008-12-05       Impact factor: 2.796

Review 9.  Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus.

Authors:  E Vermeire; J Wens; P Van Royen; Y Biot; H Hearnshaw; A Lindenmeyer
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 10.  The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review.

Authors:  J A Cramer; A Benedict; N Muszbek; A Keskinaslan; Z M Khan
Journal:  Int J Clin Pract       Date:  2007-11-05       Impact factor: 2.503

View more
  5 in total

1.  Patient Preferences for Pharmacological Diabetes Treatment Among People with Diabetes in Spain: A Discrete Choice Experiment.

Authors:  Fernando Gómez-Peralta; María Mareque; Álvaro Muñoz; Mercedes Maderuelo; Miguel Ángel Casado
Journal:  Diabetes Ther       Date:  2021-11-18       Impact factor: 2.945

2.  Patients' Views on the Design of DiabeText, a New mHealth Intervention to Improve Adherence to Oral Antidiabetes Medication in Spain: A Qualitative Study.

Authors:  Rocío Zamanillo-Campos; Maria Jesús Serrano-Ripoll; Joana Maria Taltavull-Aparicio; Elena Gervilla-García; Joana Ripoll; Maria Antonia Fiol-deRoque; Anne-Marie Boylan; Ignacio Ricci-Cabello
Journal:  Int J Environ Res Public Health       Date:  2022-02-08       Impact factor: 3.390

3.  Perspectives and Views of Primary Care Professionals Regarding DiabeText, a New mHealth Intervention to Support Adherence to Antidiabetic Medication in Spain: A Qualitative Study.

Authors:  Rocío Zamanillo-Campos; Maria Jesús Serrano-Ripoll; Joana Maria Taltavull-Aparicio; Elena Gervilla-García; Joana Ripoll; Maria Antonia Fiol-deRoque; Anne-Marie Boylan; Ignacio Ricci-Cabello
Journal:  Int J Environ Res Public Health       Date:  2022-04-01       Impact factor: 3.390

4.  Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly.

Authors:  Antoni Sicras-Mainar; Ruth Navarro-Artieda
Journal:  Drug Des Devel Ther       Date:  2014-06-18       Impact factor: 4.162

5.  [Adherence of Type 2 Diabetes Mellitus approach: Current situation and possible solutions].

Authors:  Domingo Orozco-Beltrán; Manel Mata-Cases; Sara Artola; Pedro Conthe; Javier Mediavilla; Carlos Miranda
Journal:  Aten Primaria       Date:  2016-01-13       Impact factor: 1.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.